Log In
Print
BCIQ
Print
Print this Print this
 

ATX-MS-1467

  Manage Alerts
Collapse Summary General Information
Company Apitope International N.V.
DescriptionVaccine containing four peptides derived from human myelin basic protein
Molecular Target Major histocompatibility complex class I (MHC)
Mechanism of ActionVaccine
Latest Stage of DevelopmentPhase I/II
IndicationMultiple sclerosis (MS)
Partner

Merck KGaA
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today